IntelGenx Technologies Corp. Maximum: 2,000,000 Shares of Series A Convertible Cumulative Preferred Stock $0.00001 par value per share SELLING AGENCY AGREEMENTSelling Agency Agreement • February 20th, 2024 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
IntelGenx Technologies Corp., a Delaware corporation (the "Company"), proposes, subject to the terms and conditions contained in this Selling Agency Agreement (this "Agreement"), to issue and sell on a "best efforts" basis up to a maximum of 2,000,000 shares of series A convertible cumulative preferred stock, $0.00001 par value per share (the "Preferred Stock") of the Company to investors (collectively, the "Investors"), at a purchase price of $10.00 per share (the "Purchase Price"), in an offering (the "Offering") pursuant to Regulation A through Digital Offering, LLC (the "Selling Agent"), acting on a best efforts basis only, in connection with such sales. The shares of Preferred Stock to be sold in this offering are referred to herein as the "Shares." The Shares are more fully described in the Offering Statement (as hereinafter defined).
